BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2360465)

  • 1. Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.
    Paoletti P; Butti G; Knerich R; Gaetani P; Assietti R
    Acta Neurochir (Wien); 1990; 103(1-2):35-46. PubMed ID: 2360465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful chemotherapy for recurrent malignant oligodendroglioma.
    Cairncross JG; Macdonald DR
    Ann Neurol; 1988 Apr; 23(4):360-4. PubMed ID: 3382171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.
    Schold SC; Herndon JE; Burger PC; Halperin EC; Vick NA; Cairncross JG; Macdonald DR; Dropcho EJ; Morawetz R; Bigner DD
    J Clin Oncol; 1993 Jan; 11(1):77-83. PubMed ID: 8418246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6 -dioxodiethylester) in recurring supratentorial malignant brain gliomas--a Phase II study. EORTC Brain Tumour Cooperative Group.
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):143-6. PubMed ID: 4038653
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary intracranial gliomas: clinical studies and treatment regimens of the Brain Tumor Research Center, University of California, San Francisco, 1977-1979.
    Levin VA; Wilson CB; Vestnys PS
    Cancer Treat Rep; 1981; 65 Suppl 2():83-8. PubMed ID: 7049363
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitrosourea chemotherapy for primary malignant gliomas.
    Levin VA; Wilson CB
    Cancer Treat Rep; 1976 Jun; 60(6):719-24. PubMed ID: 954010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy of brain tumors].
    García del Muro Solans J; Martí Massó JF
    Neurologia; 1988; 3(1):19-25. PubMed ID: 3078754
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy: adjuvant to surgery and radiation therapy.
    Walker MD
    Semin Oncol; 1975 Mar; 2(1):69-72. PubMed ID: 137527
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy: the agents in current use.
    Levin VA; Wilson CB
    Semin Oncol; 1975 Mar; 2(1):63-7. PubMed ID: 795035
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.
    Da Silva VF; Raaphorst GP; Goyal R; Feeley M
    J Neurosurg; 1987 Dec; 67(6):885-8. PubMed ID: 3681426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months].
    Paillas JE; Prince MA; Hassoun J; Pellet W; Peragut JC
    Rev Neurol (Paris); 1979 Mar; 135(3):251-62. PubMed ID: 227020
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of in vitro cloning assays for drug sensitivity testing of human brain tumours.
    Berens ME; Giblin JR; Dougherty DV; Hoifodt HK; Tveit K; Rosenblum ML
    Br J Neurosurg; 1988; 2(2):227-34. PubMed ID: 3267306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for malignant gliomas.
    Kyritsis AP
    Oncology (Williston Park); 1993 Sep; 7(9):93-100; discussion 103, 106. PubMed ID: 8217533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy in malignant gliomas].
    Heuser K
    Neurochirurgia (Stuttg); 1990 Oct; 33 Suppl 1():20-2. PubMed ID: 2293042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL
    Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
    [No Abstract]   [Full Text] [Related]  

  • 16. Local treatment of malignant brain tumors using implantable chemotherapeutic polymers.
    Gallia GL; Brem S; Brem H
    J Natl Compr Canc Netw; 2005 Sep; 3(5):721-8. PubMed ID: 16194460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas.
    Trojanowski T; Turowski K; Peszyński J; Koźniewska H
    J Neurooncol; 1990 Feb; 8(1):93-4. PubMed ID: 2319296
    [No Abstract]   [Full Text] [Related]  

  • 18. Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.
    Friedman HS; Schold SC; Djang WT; Kurtzberg J; Longee DC; Halperin EC; Falletta JM; Coleman RE; Oakes WJ
    Neurology; 1989 Jan; 39(1):62-6. PubMed ID: 2783351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.
    Schold SC; Rawlings CE; Bigner SH; Bigner DD
    Neurosurgery; 1983 Jun; 12(6):672-7. PubMed ID: 6683794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contemporary role of chemotherapy in the treatment of malignant brain tumor.
    Walker MD
    Clin Neurosurg; 1978; 25():388-96. PubMed ID: 710004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.